Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Sabbagh

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
International Journal of Alzheimer'S Disease|January 5, 2012
New acetylcholinesterase inhibitors for Alzheimer's diseaseMona Mehta, Abdu Adem, Marwan Sabbagh
Expert Opinion on Investigational Drugs|April 8, 2014
Investigational drugs in Alzheimer's disease: current progressCamryn Berk, Gaurav Paul, Marwan Sabbagh
Alzheimer'S Research & Therapy|October 5, 2018
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?Jana Crum, Jeffrey Wilson, Marwan Sabbagh
Neurology and Therapy|December 14, 2019
Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID TechnologyLih-Fen Lue, Yu-Min Kuo, Marwan Sabbagh
The New England Journal of Medicine|April 26, 2023
Lecanemab in Early Alzheimer's Disease. ReplyChristopher H van Dyck, Marwan Sabbagh, Sharon Cohen
Current Alzheimer Research|September 7, 2012
Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controlsIra L Goldknopf, Helen R Park, Marwan Sabbagh
International Journal of Alzheimer'S Disease|November 25, 2011
Potential peripheral biomarkers for the diagnosis of Alzheimer's diseaseSeema Patel, Raj J Shah, Paul Coleman, et al.
International Journal of Alzheimer'S Disease|April 27, 2012
Novel therapeutics in Alzheimer's diseaseMarwan Sabbagh, Anton P Porsteinsson, Anil Nair, et al.
International Journal of Alzheimer'S Disease|July 11, 2012
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?Lih-Fen Lue, Cassandra Andrade, Marwan Sabbagh, et al.
Journal of Neuropathology and Experimental Neurology|February 12, 2024
Impact of incidental synucleinopathy in mild cognitive impairment due to Alzheimer diseaseJahnavi Shriram, Michael Malek-Ahmadi, Chase Irwin, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
International Journal of Alzheimer'S Disease|January 5, 2012
New acetylcholinesterase inhibitors for Alzheimer's diseaseMona Mehta, Abdu Adem, Marwan Sabbagh
Expert Opinion on Investigational Drugs|April 8, 2014
Investigational drugs in Alzheimer's disease: current progressCamryn Berk, Gaurav Paul, Marwan Sabbagh
Alzheimer'S Research & Therapy|October 5, 2018
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?Jana Crum, Jeffrey Wilson, Marwan Sabbagh
Neurology and Therapy|December 14, 2019
Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID TechnologyLih-Fen Lue, Yu-Min Kuo, Marwan Sabbagh
The New England Journal of Medicine|April 26, 2023
Lecanemab in Early Alzheimer's Disease. ReplyChristopher H van Dyck, Marwan Sabbagh, Sharon Cohen
Current Alzheimer Research|September 7, 2012
Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controlsIra L Goldknopf, Helen R Park, Marwan Sabbagh
International Journal of Alzheimer'S Disease|November 25, 2011
Potential peripheral biomarkers for the diagnosis of Alzheimer's diseaseSeema Patel, Raj J Shah, Paul Coleman, et al.
International Journal of Alzheimer'S Disease|April 27, 2012
Novel therapeutics in Alzheimer's diseaseMarwan Sabbagh, Anton P Porsteinsson, Anil Nair, et al.
International Journal of Alzheimer'S Disease|July 11, 2012
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?Lih-Fen Lue, Cassandra Andrade, Marwan Sabbagh, et al.
Journal of Neuropathology and Experimental Neurology|February 12, 2024
Impact of incidental synucleinopathy in mild cognitive impairment due to Alzheimer diseaseJahnavi Shriram, Michael Malek-Ahmadi, Chase Irwin, et al.
Pageof 10